Both ST32db and ST32C can upregulate ATF3; however, their anti-obesity effects are weaker than those of tanshinone I and II, whose effects can be sustained for approximately 5 to 6 weeks after treatment. This evidence concerns the gene ATF3 and obesity due to melanocortin 4 receptor deficiency.